Scientists developed a therapeutic approach to generate transient antifibrotic CAR T cells in vivo by delivering modified mRNA in T cell–targeted lipid nanoparticles.
[Science]
Sorry, but the selected Zotpress account can't be found.
Sorry, but the selected Zotpress account can't be found.